Millennium Pharmacon International - Asset Resilience Ratio

Latest as of September 2023: -0.72%

Millennium Pharmacon International (SDPC) has an Asset Resilience Ratio of -0.72% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Millennium Pharmacon International asset portfolio for the complete picture of this company's asset base.

Liquid Assets

Rp-11.22 Billion
≈ $-657.22K USD Cash + Short-term Investments

Total Assets

Rp1.55 Trillion
≈ $90.93 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2021)

This chart shows how Millennium Pharmacon International's Asset Resilience Ratio has changed over time. See Millennium Pharmacon International (SDPC) net asset quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Millennium Pharmacon International's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Millennium Pharmacon International market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rp0.00 0%
Short-term Investments Rp-11.22 Billion -0.72%
Total Liquid Assets Rp-11.22 Billion -0.72%

Asset Resilience Insights

  • Limited Liquidity: Millennium Pharmacon International maintains only -0.72% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Millennium Pharmacon International Industry Peers by Asset Resilience Ratio

Compare Millennium Pharmacon International's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jointown Pharmaceutical Group Co Ltd
SHG:600998
Medical Distribution 0.08%
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.21%

Annual Asset Resilience Ratio for Millennium Pharmacon International (2000–2021)

The table below shows the annual Asset Resilience Ratio data for Millennium Pharmacon International.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2021-12-31 -1.73% Rp-20.88 Billion
≈ $-1.22 Million
Rp1.21 Trillion
≈ $70.69 Million
+0.54pp
2020-12-31 -2.27% Rp-26.47 Billion
≈ $-1.55 Million
Rp1.16 Trillion
≈ $68.25 Million
+0.39pp
2019-12-31 -2.66% Rp-32.71 Billion
≈ $-1.92 Million
Rp1.23 Trillion
≈ $72.12 Million
-1.24pp
2018-12-31 -1.42% Rp-16.91 Billion
≈ $-990.95K
Rp1.19 Trillion
≈ $69.90 Million
+0.27pp
2017-12-31 -1.69% Rp-15.86 Billion
≈ $-929.61K
Rp938.01 Billion
≈ $54.96 Million
-1.71pp
2002-12-31 0.01% Rp15.90 Million
≈ $931.50
Rp108.27 Billion
≈ $6.34 Million
-2.88pp
2000-12-31 2.89% Rp3.28 Billion
≈ $192.10K
Rp113.38 Billion
≈ $6.64 Million
--
pp = percentage points

About Millennium Pharmacon International

JK:SDPC Indonesia Medical Distribution
Market Cap
$14.18 Million
Rp242.06 Billion IDR
Market Cap Rank
#26167 Global
#578 in Indonesia
Share Price
Rp190.00
Change (1 day)
+5.56%
52-Week Range
Rp125.00 - Rp202.00
All Time High
Rp357.65
About

PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more